You are viewing: Australia Diabetes Care Devices Market analysis
Part of: Diabetes Care Devices Market (Global)

The Australia Diabetes Care Devices Market was valued at $654.2 Million in 2025 and projected to reach to $1239.1 Million by 2030, representing a compound annual growth rate of 13.6%. Australia's diabetes care devices market is positioned for exceptional growth through 2030, driven by rising Type 2 diabetes incidence, an aging population, and strong healthcare infrastructure.

Australia Diabetes Care Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Australia Diabetes Care Devices Market Trends and Insights

  • This expansion reflects Australia's aging population, rising diabetes prevalence, and increasing healthcare investment in chronic disease management.
  • Australia's market growth rate of 13.6% CAGR significantly outpaces global trends, driven by strong adoption of continuous glucose monitoring systems, insulin delivery devices, and digital health integration across the country. The Australian diabetes care devices sector benefits from advanced healthcare infrastructure, government reimbursement policies, and growing consumer awareness of preventive care.
  • Australia's regulatory environment supports rapid innovation and device approval, enabling manufacturers to bring cutting-edge solutions to market efficiently.
  • Between 2025 and 2030, Australia is expected to see accelerated demand for connected and smart devices that integrate with mobile health platforms, reflecting the nation's digital health transformation and commitment to improving diabetes outcomes..

Key Market Statistics

  • CAGR (2025-2030) 13.6% CAGR
  • Market Size, 2025 ~USD 654.2 Million
  • Forecast, 2030 ~USD 1239.1 Million
  • Country Australia

Australia Diabetes Care Devices Market Overview

Rapid Market Expansion :

Australia's diabetes care devices market is growing at 13.6% CAGR, significantly outpacing the global rate of 12.3%, driven by increasing diabetes prevalence and healthcare modernization across the country.

Aging Population Dynamics :

Australia's demographic shift toward an older population is accelerating diabetes diagnosis and management needs, creating sustained demand for advanced monitoring and insulin delivery devices.

Strong Healthcare Investment :

Increased government funding for chronic disease management and National Diabetes Services Scheme (NDSS) support are expanding patient access to subsidized diabetes care devices across all socioeconomic segments.

Market Valuation Growth :

The market is valued at USD 654.2 million in 2025 and is projected to nearly double to USD 1,239.1 million by 2030, representing substantial investment opportunities for device manufacturers and distributors.

Australia Diabetes Care Devices Market Dynamics

  • The National Diabetes Services Scheme continues to improve device accessibility, while technological innovations in continuous glucose monitoring and insulin pumps gain market traction.
  • Healthcare providers are increasingly adopting integrated digital health solutions, creating opportunities for connected device ecosystems.
  • Government initiatives supporting preventive care and chronic disease management further bolster market expansion.
  • The competitive landscape remains dynamic, with both established multinational players and emerging local innovators capturing market share through tailored solutions for the Australian healthcare system..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Australia's diabetes care devices market will nearly double from USD 654.2M (2025) to USD 1,239.1M (2030), representing a 13.6% CAGR.
    • Australia's growth rate outpaces the global average of 12.3%, driven by aging demographics and rising diabetes incidence across the country.
    • Continuous glucose monitoring and smart insulin delivery systems are leading growth segments in Australia's market.
    • Australia's strong healthcare infrastructure and digital health initiatives position the country as a key growth market in the Asia Pacific region.

    Diabetes Care Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIABETES MANAGEMENT MOBILE APPLICATIONS (Product Type)
    Forecast Period 2025-2030
    Growth Rate CAGR of 12.3% from 2025 to 2030
    Largest Segment TYPE 2 DIABETES (Disease Type)
    Market Size Base Year (Billions) ~USD 34.27 (2025)
    Revenue Forecast (Billions) ~USD 61.2 (2030)
    Segments Covered Product Type, Type, Disease Type, Patient Care Settings

    Australia Diabetes Care Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product Type

    • Blood Glucose Monitoring System
    • Blood Glucose Monitoring Systems
    • Diabetes Management Mobile Applications
    • Insulin Delivery Devices

    By Type

    • Continuous Glucose Monitoring Systems
    • Disposable Insulin Pens
    • Insulin Pens
    • Insulin Pumps & Accessories
    • Insulin Syringes & Needles
    • Lancets/Lancing Devices
    • Other Insulin Delivery Devices
    • Pen Needles
    • Reusable Insulin Pens
    • Self-Monitoring Blood Glucose Systems
    • Test Strips/ Test Papers
    • Test Strips/Test Papers
    • Tethered Insulin Pumps
    • Tubeless Insulin Pumps

    By Disease Type

    • Type 1 Diabetes
    • Type 2 Diabetes

    By Patient Care Settings

    • Hospitals & Diabetes Specialty Clinics
    • Self/ Home Healthcare
    • Self/Home Healthcare

    Target Audience

    • Medical Device Manufacturers : Manufacturers need Australia-specific market data to develop localized product strategies, identify unmet clinical needs, and optimize market entry timing in this high-growth region.
    • Healthcare Distributors & Retailers : Distributors require detailed market forecasts and segment analysis to optimize inventory management, negotiate supplier contracts, and identify emerging product categories with highest growth potential.
    • Healthcare Investors & Private Equity : Investors need comprehensive market sizing and growth projections to evaluate acquisition targets, assess portfolio company performance, and identify emerging opportunities in Australia's diabetes care sector.
    • Government & Healthcare Policy Makers : Policy makers require market intelligence to inform NDSS program adjustments, healthcare budget allocation, and chronic disease management initiatives aligned with market realities and patient needs.
    • Healthcare Consultants & Advisors : Consultants need Australia-specific market data to support client strategy development, competitive analysis, and market entry planning for diabetes care device companies targeting the region.

    Reasons to Buy this Report

    • Market-Specific Growth Intelligence : Gain detailed insights into Australia's 13.6% CAGR trajectory and understand the unique drivers differentiating this market from global trends, enabling targeted business strategy development.
    • Demographic & Healthcare Opportunity Analysis : Access comprehensive data on Australia's aging population dynamics, NDSS subsidy landscape, and healthcare investment patterns to identify high-potential customer segments and distribution channels.
    • Competitive Positioning Framework : Benchmark your organization against market leaders in Australia's diabetes device sector with localized competitive intelligence, pricing strategies, and market share distribution analysis.
    • Forecast-Driven Investment Planning : Leverage precise market projections (USD 654.2M to USD 1,239.1M by 2030) to inform capital allocation, product development priorities, and market entry or expansion decisions in Australia.
    • Regulatory & Reimbursement Insights : Understand Australia-specific regulatory requirements, TGA approval pathways, and NDSS reimbursement mechanisms to accelerate product commercialization and market penetration strategies.

    Frequently asked questions

    What is the current size of Australia's diabetes care devices market?

    Australia's diabetes care devices market is valued at USD 654.2 million in 2025 and is projected to grow to USD 1,239.1 million by 2030.

    What is the growth rate for diabetes care devices in Australia?

    Australia's diabetes care devices market is growing at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2030.

    Which devices are driving growth in Australia's diabetes care market?

    Continuous glucose monitoring systems, smart insulin pumps, and connected blood glucose meters are the primary growth drivers in Australia's market.

    How does Australia's market growth compare to global trends?

    Australia's 13.6% CAGR exceeds the global average of 12.3%, reflecting strong market dynamics and healthcare investment specific to the country.

    What factors are supporting diabetes device adoption in Australia?

    Australia's aging population, rising diabetes prevalence, advanced healthcare infrastructure, government reimbursement policies, and digital health initiatives are key adoption drivers.

    RESEARCH METHODOLOGY

    The study involved four main activities to estimate the current size of the diabetes care devices market. First, extensive secondary research was conducted to gather information about the market, including related and parent markets. The next step was validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Both top-down and bottom-up methods were used to develop a comprehensive estimate of the overall market size. Lastly, market segmentation and data triangulation techniques were employed to determine the sizes of segments and subsegments within the market.

    Secondary Research

    The secondary research process involved extensive use of various sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the diabetes care devices market. It also helped obtain critical insights about key industry players, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.

    Primary Research

    In the primary research process, we conducted interviews with various sources from both the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts, including CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations involved in the diabetes care devices market, were interviewed. For the demand side, engagement with industry experts, purchase and sales managers, doctors, and personnel from research organizations was done. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.

    A breakdown of the primary respondents for the diabetes care devices market is provided below:

    Diabetes Care Devices Market

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the diabetes care devices market includes the following details.

    The market sizing was undertaken from the global side.

    Country-level Analysis: The size of the diabetes care devices market was determined from annual presentations by leading companies and publicly available secondary data. The share of products and services within the overall diabetes care devices market was calculated using secondary data and verified by primary participants to arrive at the total market size. Primary participants also further validated the data numbers.

    Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each stage, the assumptions and approaches were verified with industry experts contacted during primary research. Due to limitations in the data from secondary research, revenue estimates for individual companies (covering the overall diabetes care devices market and geographic market assessment) were determined based on a detailed analysis of their product offerings, geographic reach or strength (whether direct or through distributors or suppliers), and the market shares of leading players in specific regions and countries.

    Global Diabetes Care Devices Market Size: Bottom-up and Top-down Approach

    Diabetes Care Devices Market

    Data Triangulation

    After determining the overall size from the market size estimation process described above, the total market was divided into several segments and subsegments. The data triangulation and market breakdown procedures outlined below were applied, where appropriate, to complete the overall market analysis and obtain precise statistics for various segments. The data was triangulated by examining different factors and trends from both demand and supply perspectives. Additionally, the market size was validated using both the top-down and bottom-up approaches.

    Market Definition

    The diabetes care devices includes medical technologies and tools used for monitoring, managing, and treating diabetes. It features blood glucose monitoring systems (such as glucometers, continuous glucose monitors, test strips, and lancets), insulin delivery devices (including insulin pens, pumps, syringes, and automated delivery systems), and related accessories. These devices help track glucose accurately, deliver insulin effectively, and improve patient outcomes by enabling better disease control, reducing complications, and enhancing quality of life. The market serves patients, healthcare providers, and caregivers and is driven by technological innovations, the rising prevalence of diabetes, and increasing demand for connected, user-friendly solutions.

    Stakeholders

    • Diabetes Care Devices’ Manufacturing Companies
    • Contract Manufacturers
    • Distributors, Suppliers, and Channel Partners of Diabetes Care Devices
    • Senior Management
    • Finance Department
    • Procurement Department
    • Hospitals & Clinics
    • E-commerce and Digital Platforms
    • Retail Pharmacies and Supermarkets
    • Academic & Research Institutes
    • Trade Associations and Industry Bodies
    • Regulatory Bodies and Government Agencies
    • Business Research and Consulting Service Providers
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors

    Report Objectives

    • To define, describe, segment, analyse, and forecast the global diabetes care devices  market by product type, disease type, patient care settings, and region
    • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the diabetes care devices  market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries
    • To profile the key players in the diabetes care devices  market and comprehensively analyze their core competencies
    • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the diabetes care devices  market

     

    Get the Full Diabetes Care Devices Market Report

    Full forecast, segment splits, and company analysis for all Diabetes Care Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status